Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-03

Clinical Trial Update: GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Type IV Thoracoabdominal Aortic Aneurysms [NA]

View source ↗

Summary

Clinical trial update for the Gore EXCLUDER thoracoabdominal endoprosthesis in type IV thoracoabdominal aortic aneurysm has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis

Snippet

Sponsor: W.L.Gore & Associates | Conditions: Thoracoabdominal Aortic Aneurysm | NA | Status: COMPLETED | Results posted: 2018-07-03